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INTRODUCTION: 
AVAPRO® (irbesartan) is an angiotensin II receptor (AT1 
subtype) antagonist. Irbesartan is a non-peptide compound, 
chemically described as a 2-butyl-3-[p-(o-1Htetrazol-5-
ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one. 
Its empirical formula is C25H28N6O, and the structural 
formula: 
 
Irbesartan is a white to off-white crystalline powder with a 
molecular weight of 428.5. It is a nonpolar compound with 
a partition coefficient (octanol/water) of 10.1 at pH of 7.4. 
Irbesartan is slightly soluble in alcohol and methylene 
chloride and practically insoluble in water. AVAPRO is 
available for oral administration in unscored tablets 
containing 75 mg, 150 mg, or 300 mg of irbesartan. 
Inactive ingredients include: lactose, microcrystalline 
cellulose, pregelatinized starch, croscarmellose sodium, 
poloxamer 188, silicon dioxide, and magnesium. It has 
also been tested for use in the treatment of high blood 
pressure (hypertension) Literature survey reveals that LC, 
HPTLC, HPLC for determination of content uniformity 
and simultaneous estimation of Irbesartan is reported, but 
there is no stability indicating high-performance liquid 
chromatography (HPLC) method for the determination of 
Irbesartan from its tablets, as its Pharmaceutical dosage 
form. The International Conference on Harmonization 
(ICH) guideline entitled 'Stability Testing of New Drug 
Substances and Products' requires the stress testing to be 
carried out to elucidate the inherent stability characteristics 
of the active substance. Susceptibility to oxidation is one 
of the required tests(ICH, 1993, 1996). The hydrolytic and 
the photolytic stability are also required. An ideal stability-
indicating method is one that quantifies the drug per se and 
also resolves its degradation products. A very viable 
alternative for stability-indicating analysis of Irbesartan is 
HPLC. The aim of the present work was to develop an 
accurate, specific, reproducible, and stability indicating 
method for the determination of Irbesartan in the presence 
of its degradation products and related impurities as per 
ICH guideline. Few analytical methods for the estimation 
of Irebesartan from plasma2-3, and metabolites including 
HPTLC4-5, HPLC6-7, and GC8 are reported. To the best 
of our knowledge, a very few Spectrophotometric methods 
have been reported. In view of the above fact, some rapid 
and sensitive analytical methods are in need for its 
quantitative estimation. The present work describes two 
simple and accurate spectrophotometric methods for the 
estimation of Irbesartan in bulk and dosage form stearate. 
MATERIALS AND METHODS: 
Drug: The standard sample of Irebesrtan was obtained as 
gift sample from Dr. Reddy’s Laboratory Pvt. Ltd., 
Hyderabad, A.P., India. The Irebesrtan ablets were 
procured from local market,  manufactured by RANBAXY 
Laboratories, India. 
Instrument specifications: UV Spectrophotometer, 
Shimadzu, model 1800. 
Chemicals and reagents used: Methanol obtained from 
local market, manufactured by Merck Pharmaceuticals. 
Analytical assay - The samples were weighed on 
electronic analytical balance (Contech Model CB-50) 
Preparation of Standard Solutions  
The 10 mg of standard Irbesarten was weighed accurately 
and transferred into 100 ml volumetric flask. It was 
dissolved in methanol and diluted up to the mark by using 
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the same solvent to obtain a final concentration of 
100μg/ml. The resulting solution was used as a working 
standard solution. 
Preparation of Sample Solutions 
For the sample solution each tablet containing 150mg of 
Irebesartan 20 tablets were taken and weighed, their mean 
weight was determined and finely powdered. An 
equivalent weighed (10mg) of the tablet content was 
transferred into a100ml volumetric flask containing 50ml 
of ethanol, sonicated for 30 min and diluted to 100ml with 
ethanol. The resulting solution was sonicated for 30 min 
and filtered through Whatmann filter paper no.0.45. This 
solution was used as test solution the methods. 
Method for the Determination of detection wavelength 
Standard stock solution of Irebesartan: 150 mg of 
Irebesartan was accurately weighed and transferred into a 
clean and dry 100 ml volumetric flask, dissolved with 
sufficient volume of methanol (AR grade). The volume 
was then made up to 100 ml with methanol to obtain the 
concentration of 1000 µg/ml (1mg/ml). Working standard 
solution: 1 ml of the stock solution was further diluted up 
to 10 ml volumetric flask with methanol to get a 
concentration 100 µg/ml. Serial dilutions of concentration 
range 2-30 µg/ml were prepared from the working 
standard solution. These dilutions were scanned in the UV 
range of 200 to 400 nm using methanol as blank. The 
normal mode graphs were converted to first order 
derivative by software UV probe Shimadzu 2.34. The 
detection wavelength was thus selected.  Is shown in fig no 
– 1  
Figure 1: Wavelength scanning and determination of 
absorption maximum 
Detection wavelength was selected as 263 nm 
 
Determination of linearity 
Standard stock solution of Irebesartan: 150 mg of 
Irebesartan was accurately weighed and transferred into a 
clean and dry 100 ml volumetric flask, dissolved with 
sufficient volume of methanol (AR grade). The volume 
was then made up to 100 ml with methanol to obtain the 
concentration of 1000 µg/ml (1mg/ml). Working standard 
solution: 1 ml of the stock solution was further diluted up 
to 10 ml volumetric flask with methanol to get a 
concentration 100 µg/ml. Serial dilutions of concentration 
range 2-100 µg/ml were prepared from the working 
standard solution. These dilutions were scanned at the 
detection wavelength of 263 nm using methanol as blank. 
The normal mode graphs were converted to first order 
derivative by software UV probe Shimadzu 2.34. The 
regression equation, Y- intercept and correlation 
coefficient were calculated. The linearity was thus 
determined, and a concentration range was selected 
Figure 2: Standard Graph Of Irbesartan 
 
 Linearity in the response was obtained in the range of 10-
100µg/ml and regration equation was calculated as           
y=mx+c  
                               y=0.0253x+0.0278 
                               R2=0.999 
Figure 3: Derivative graph of the concentration range 
for Linearity 
 
Determination of Sandell’s Sensitivity 
Standard stock solution of Irebesartan: 150 mg of 
Irbesartan was accurately weighed and transferred into a 
clean and dry 100 ml volumetric flask, dissolved with 
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sufficient volume of methanol (AR grade). The volume 
was then made up to 100 ml with methanol to obtain the 
concentration of 1000 µg/ml (1mg/ml). Working standard 
solution: 1 ml of the stock solution was further diluted up 
to 10 ml volumetric flask with methanol to get a 
concentration 100 µg/ml. Serial dilutions of the 
concentration range (10-20 µg/ml) were prepared from the 
working standard solution (100µg/ml). Each of the 
dilutions was scanned a several times by changing the 
dilution in the curette during scan at the detection 
wavelength 263 nm. Convert the obtained normal mode 
graphs to first order derivative. Note down the 
observations. From this observation table take the mean of 
the columns note down the observations in a table and 
calculate the Sandell’s sensitivity from the formula below: 
Sandell’s Sensitivity (л) = Conc. (µg/100 ml) x 0.001/D1 
value 
    
Table 1: Sandell’s Sensitivity 
S .NO. CONCENTRATION 
(µg/ml ) 
ABSORBANCE SENSITIVITY MEAN 
SENSITIVITY 
1 
2 
3 
4 
5 
6 
10 
20 
30 
40 
50 
60 
0.4831 
0.6120 
0.7324 
0.8031 
1.2134 
1.3215 
1.6801 
1.6265 
1.6212 
1.6327 
1.6089 
1.6361 
1.6269 
The sandell’s sensitivity for the developed method was found to be 1.6269 The values were founds to be within the official 
limit.  
Limit of Detection and Limit of Quantitation 
The LOD and LOQ were separately determined based on 
calibration curve. The residual standard deviation of a 
regression line or the standard deviation of y- intercepts of 
regression lines were used to calculate the LOD and LOQ 
From the observation table of Sandell’s sensitivity, the 
regression equations, slope an intercept were calculated. 
The observations were noted down in observation table, 
the detection limit and quantification limit was calculated 
by statistical formula. 
Table 2: The observations table of LOD and LOQ 
SET  SLOPE  INTERCEPT  
1 
2 
3 
4 
5 
6 
0.022 
0.022 
0.022 
0.022 
0.022 
0.022 
0.69 
0.63 
0.68 
0.65 
0.68 
0.68  
  MEAN   =0.022            SD =0.000521  
 
I. Formula for LOD (µg/ml); 
 
LOD = 3.3 x SD / S    
 
Where, 
 
SD = The standard deviation of the response 
S =   The slope of the calibration curve (mean). 
 
II. Formula for LOQ (µg/ml); 
LOQ = 10 x SD / S    
Where, 
 
SD = The standard deviation of the response 
S =   The slope of the calibration curve (mean). 
Accuracy/Recovery Studies 
The stock solution of the formulation was prepared by 
following method (1mg/ml), Weigh powder equivalent to 
50 m of Irebesartan. Dissolve in approximately 30-40 ml 
of solvent (methanol). Sonicate for 20-30 mins. Make up 
the volume up to 50 ml with the solvent (methanol). Filter 
& use. A stock solution of pure drug sample was prepared 
(1mg/ml).  
The three dilutions in the following way: 
To the 0.1 ml of the standard stock solution, add 0.05 ml of 
the test stock (formulation). 
To the 0.1 ml of the standard stock solution, add 0.1 ml of 
the test stock (formulation). 
To the 0.1 ml of the standard stock solution, add 0.15 ml of 
the test stock (formulation). 
I. The three dilutions were scanned at detection 
wavelength (263 nm), and the D
1
 values were noted 
down. 
II. Amount of test recovered was calculated by the 
formula:  
(D
1
 test/ D
1
 std) x conc. of std 
 
Table 3: Accuracy study 
S.NO. TEST (µg/ml) STANDARD 
(µg/ml) 
D
1
 VALUE AT 
263 nm 
CONC. 
(µg/ml) 
AMOUNT OF TEST 
RECOVERED (µg/ml) 
% 
RECOVERY 
1 5 10 0.015 15 5 100 
2 10 10 0.020 20 10 100 
3 15 10 0.025 25 15 100 
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The percentage recovery results revealed that the value is 
100%, which indicates that the proposed method is 
accurate as the results are within the official limits.  It also 
reveals that the commonly used excipients and additives in 
the formulation were not interfering with the proposed 
method. 
 
Assay 
A method to analyze or quantify a substance in a sample. 
An assay is an analysis done to determine:  
1. The presence of a substance and the amount of that 
substance.  
2. The biological or pharmacological potency of a drug.
 
Table 4: Depicting the assay study 
S.NO. CONC. (µg/ml) D
1
 VALUE AT 263 nm AMOUNT OBTAINED (mg) % PURITY 
(w/w) 
1 12 0.010 6.32 92.44 
2 14 0.014 5.26 87.49 
3 16 0.019 4.38 83.47 
 
The percentage purity of three different samples, 12, 14 
and 16µg/ml was found to be 92.44%, 87.49% and 83.47% 
respectively. 
RESULT AND DISCUSSION: 
Develop some new and sensitive analytical methods for 
the determination and validation of Irebesartan in bulk and 
pharmaceutical dosage forms. Detection wavelength was 
selected as 263 nm Linearity in response was observed in 
the range of 10-100 µg/ml having R
2
 = 0.999. ( R
2=
 not 
less then  .996 )
 
 The regeration equ. y=0.0253x+0.0278  
was calculated   as Y = The sandell’s sensitivity for the 
developed method was found to be1.6269. The values 
were founds to be  within the official limit. The percentage 
purity of three different samples, 12, 14, and 16µg/ml was 
found to be 92.44 ,87.49, 83.47respectively. The 
percentage recovery results revealed that the value is 
100%, which indicates that the proposed method is 
accurate as the results are within the official limits.  It also 
reveals that the commonly used excipients and additives in 
the formulation were not interfering with the proposed 
method 
CONCLUSION: 
In view of the results, it can be inferred that the UV 
Spectroscopy may be applied to the determination of 
Irbesartan as an alternative to the Other UV methods and 
analytical HPLC methods. Although the precisions of both 
methods are similar, estimation of Irebesartan is slightly 
more exact in the derivative approach. Thus, it can be 
concluded that the Method Developed by the Spectroscopy 
in the present investigation is simple, sensitive, accurate, 
rapid and precise. Hence, the above said method can be 
successfully applied for the estimation of Irebesartan.
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